Good research practice is one of the foundations of high-quality research. Robust, reliable and reproducible studies are fundamental to driving scientific progress.
On this page
We expect the people we fund to adhere to high standards of research integrity and rigour. This includes how research is planned, performed, reported and shared.
We expect our researchers to follow:
- our guidelines on good research practice
- the Universities UK Concordat to support research integrity, of which we’re a signatory.
What we’re doing
Research involving animals
For years we’ve worked to influence policy and develop a more open dialogue around how the practice of research involving animals can be improved.
Concordat to support research integrity
We’re a member of the working group that supports the Universities UK Concordat on research integrity.
Improving the reproducibility of research
One element of good research practice is reproducibility. To develop and implement ways to improve the reproducibility of biomedical research, we’ve partnered with the:
- Academy of Medical Sciences
- Biotechnology and Biological Sciences Research Council
- Medical Research Council.
As part of our commitment, we jointly organised a symposium in April 2015. Read the summary
Our joint statement outlines the key activities that we’ve undertaken since the symposium to improve research reproducibility. We recognise that it’s a system-wide issue that requires action, not just from us, but from publishers, research organisations and members of the wider biomedical research community.
- Read our statement on the handling of allegations of research misconduct.
- See the findings of the Nuffield Council on Bioethics’ project on the culture of scientific research in the UK.
- Read the UK Research Integrity Office’s good research practice guidance for researchers.
- Find out more about overcoming the challenges of reproducible research in Sir David Spiegelhalter’s interview for the Royal Society.
If you have any questions, contact Alice Jamieson
Science policy affects a broad range of issues, ranging from data sharing and gene editing, to intellectual property and regulation.